Log in to search using one of your social media accounts:

 

Artificial Intelligence in Medicine: Hope or Hype?

The use of Artificial Intelligence (AI) is on the rise in the technology sector and has become a buzz-worthy topic in many corners of our digital world. The application of AI in the medical field holds great promise for improving patient health, but will doctors and patients feel comfortable using it? Young startups have begun leveraging this technology to prove better health outcomes, but there's still a lot to do before we'll see AI used pervasively in the clinic. Current Landscape To date, the sweet spot in healthcare AI has been pairing algorithms with structured exercises in reading patient data and medical images to train machines to detect abnormalities. This training is called “deep learning.” In the same way, algorithms are being used to sift through vast amounts of medical literature to inform treatment decisions where it would be too onerous a task to have a human read through the same journals. Companies like MedyMatch and Viz are doing just that. They’re using proprietary algorithms and applying deep learning to aid physicians in making faster diagnoses of strokes in emergency treatment situations. Their algorithms produce an output by ingesting patient CT scans and using the programmed deep learning to aid in the diagnosis of a stroke. Advancement in this particular instance is especially significant because receiving appropriate treatment quickly has a big impact on patient outcomes. Learn more about the hype vs. the reality of artificial int...
Source: MDDI - Category: Medical Devices Authors: Tags: Software Source Type: news

Related Links:

An integrated analysis of safety data from seven Phase 2/3 double-blind, placebo-controlled trials has been conducted for ospemifene (Senshio ®). Adverse drug reactions are well characterized, benign and not unexpected from a SERM used for the treatment of VVA (i.e. hot flushes, leg cramps). There is no evidence to date that ospemifene leads to an increase in vaginal bleeding, endometrial hyperplasia or cancer; VTE, stroke or other cardi ovascular events; or any other adverse event of special interest.
Source: Maturitas - Category: Primary Care Authors: Source Type: research
CONCLUSIONS: Although the VHA's equal access health care system has reduced many racial/ethnic mortality disparities present in the private sector, our review identified mortality disparities that have persisted mainly for Black veterans in several clinical areas. However, because most mortality disparities were supported by single studies with imprecise findings, we could not draw strong conclusions about this evidence. More disparities research is needed for American Indian and Alaska Native, Asian, and Hispanic veterans overall and for more of the largest life expectancy gaps. Public Health Implications. Because of the ...
Source: American Journal of Public Health - Category: International Medicine & Public Health Authors: Tags: Am J Public Health Source Type: research
Engineers, doctors and scientists at UCLA and Rutgers University have developed a tool that measures the physical strength of individual cells 100 times faster than current technologies.The new device could make it easier and faster to test and evaluate new drugs for diseases associated with abnormal levels of cell strength, including hypertension, asthma and muscular dystrophy. It could also open new avenues for biological research into cell force. It is the first high-throughput tool that can measure the strength of thousands of individual cells at a time.“Our tool tracks how much force individual cells exert over ...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Conclusion Pain is a critical underestimated problem in elderly patients. A timely systematic evaluation of the pain would call attention to palliative care needs and reduce the negative effects of uncontrolled pain on the quality of life.
Source: International Journal of Gerontology - Category: Geriatrics Source Type: research
ConclusionWhile cancer therapies are known to increase the risk of CVD, this study additionally shows that CVD risk varies by sociodemographic factors.Implications for cancer survivorsThe identification and mitigation of CVD risk factors in these subgroups may improve long-term patient outcomes.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research
AbstractThe aim of this study was to quantify the population impact of rheumatic and musculoskeletal diseases (RMDs) with other non-communicable diseases (NCDs), using two complementary strategies: standard multivariate models based on global burden of disease (GBD)-defined groups vs. empirical mutually exclusive patterns of NCDs. We used cross-sectional data from the Portuguese Fourth National Health Survey (n = 23,752). Six GBD-defined groups were included: RMDs, chronic obstructive pulmonary disease or asthma, cancer, depression, diabetes or renal failure, and stroke or myocardial infarction. The empirical...
Source: Rheumatology International - Category: Rheumatology Source Type: research
The Department of Health and Human Services (HHS) announced on January 31, 2018, that Dr. Brenda Fitzgerald would resign as the Director of the Centers for Disease Control and Prevention (CDC). The statement read, “Dr. Fitzgerald owns certain complex financial interests that have imposed a broad recusal limiting her ability to complete all of her duties as the CDC Director. Due to the nature of these financial interests, Dr. Fitzgerald could not divest from them in a definitive time period.” The decision came a day after Politico reported that she bought stock in a large tobacco company within a month of start...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
In a recent article in the journal, Patell et al1 found CHADS2 and CHA2DS2VASC to predict risk of ischemic stroke in cancer patients with baseline atrial fibrillation (AF). Although only 36% of patients received anticoagulant therapy, the risk of stroke generally appeared to be lower than in cancer-free individuals2,3. Given the size and statistical rigor of the analysis, and the perplexing paucity of published data regarding the management of coexisting AF and cancer, the study by Patell et al1 is of outstanding worth.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Dear Colleagues: Welcome to the January-February 2018 issue of Innovations in Clinical Neuroscience (ICNS). This is a milestone year for us as it marks the beginning of our 15th year of publication! We are pleased to continue serving you, our valued readers and colleagues, by providing peer-reviewed, evidence-based information on the latest innovations in both research and clinical practice in the field of neuroscience. We’d like to thank those dedicated readers who have been with us since 2004, the year we launched the journal, and to welcome new readers who are just discovering ICNS and what it has to offer. We&rsq...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Current Issue Editor's Message: Issue Highlights Source Type: research
AbstractRationale:Repeated occurring stroke in short intervals with hypercoagulability is unusual so in such cases the conventional vascular risk factors might not be the causes of stroke.Patient concerns:We have presented a case of 60-year-old male presenting with recurrent stroke due to thrombophilia.Diagnoses:Lung cancer was detected by superficial lymph nodes ultrasound and further pathological examination.Interventions:The patient suffered a recurrent stroke and he had persistently high level of D-dimer which suggested the diagnosis of thrombophilia, thus, he was treated with low-molecular-weight heparin. Unfortunatel...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
More News: Cancer | Cancer & Oncology | Computers | Conferences | CT Scan | Emergency Medicine | HIPAA | Learning | Lung Transplant | Partnerships | PET Scan | Radiology | Stroke | Training | Universities & Medical Training